BMC Neurology 2010-01-01

Neuroprotective properties of levosimendan in an in vitro model of traumatic brain injury.

Anna B Roehl, Marc Hein, Philipp D Loetscher, Jan Rossaint, Joachim Weis, Rolf Rossaint, Mark Coburn

Index: BMC Neurol. 10 , 97, (2010)

Full Text: HTML

Abstract

We investigated the neuroprotective properties of levosimendan, a novel inodilator, in an in vitro model of traumatic brain injury.Organotypic hippocampal brain slices from mouse pups were subjected to a focal mechanical trauma. Slices were treated after the injury with three different concentrations of levosimendan (0.001, 0.01 and 0.1 μM) and compared to vehicle-treated slices. After 72 hrs, the trauma was quantified using propidium iodide to mark the injured cells.A significant dose-dependent reduction of both total and secondary tissue injury was observed in cells treated with either 0.01 or 0.1 μM levosimendan compared to vehicle-treated slices.Levosimendan represents a promising new pharmacological tool for neuroprotection after brain injury and warrants further investigation in an in vivo model.

Related Compounds

  • Levosimendan

Related Articles:

Levosimendan exerts anti-inflammatory effects on cardiac myocytes and endothelial cells in vitro.

2015-02-01

[Thromb. Haemost. 113(2) , 350-62, (2015)]

Effect of levosimendan on the contractility of muscle fibers from nemaline myopathy patients with mutations in the nebulin gene.

2015-01-01

[Skelet. Muscle 5 , 12, (2015)]

A Bayesian network meta-analysis on the effect of inodilatory agents on mortality.

2015-05-01

[Br. J. Anaesth. 114 , 746-56, (2015)]

Influence of levosimendan postconditioning on apoptosis of rat lung cells in a model of ischemia-reperfusion injury.

2015-01-01

[PLoS ONE 10(1) , e0114963, (2015)]

The effects of levosimendan on brain metabolism during initial recovery from global transient ischaemia/hypoxia.

2012-01-01

[BMC Neurol. 12 , 81, (2012)]

More Articles...